NCT00003125: Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors |
|
|
| Completed | 2 | 24 | US | ALVAC-CEA vaccine, aldesleukin, sargramostim, vaccinia-CEA vaccine | Georgetown University, National Cancer Institute (NCI) | Breast Cancer, Esophageal Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 11/04 | 11/04 | | |
